IP Library Granted Patent US 10,926,086
Granted Patent B2
US 10,926,086 · App. 16/075,161 · Granted Feb 23, 2021

Lymphatic system neuromodulation and uses thereof

Inventors: Sangeeta S. Chavan (Syosset, NY); William M. Hanes (East Setauket, NY); Kevin J. Tracey (Old Greenwich, CT)
Assignee: The Feinstein Institutes for Medical Research
A61N1/36002A61K41/00A61N1/36017A61N1/36034A61N1/36146A61N1/36175A61N2/006A61N2/02A61K39/00A61K2039/575A61N1/0456A61N1/36171
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,926,086
App. No.
16/075,161
Granted
Feb 23, 2021
Kind
B2
Abstract

Methods are disclosed for preventing systemic infection or controlling metastases or providing a vaccine adjuvant in a subject, the methods comprising stimulating one or more peripheral nerves innervating one or more lymph nodes of the subject.

Claims (15)

1. A method of inhibiting systemic infection by infectious pathogens in a subject, the method comprising electrical and/or magnetic stimulation of one or more peripheral nerves innervating one or more lymph nodes draining a site of infection in the subject to constrain the infectious pathogens from traveling through the subject's lymphatic system, wherein unconstrained travel of the infectious pathogens through the subject's lymphatic system leads to systemic infection, thereby inhibiting systemic infection by the infectious pathogens in the subject;

wherein the electrical stimulation of the one or more peripheral nerves comprises a train of 0.75 msec duration pulses applied at 2-20 Hz, or wherein the magnetic stimulation of the one or more peripheral nerves comprises a train of pulses applied at 2 Hz using an electromagnetic coil that creates a time-variable magnetic field.

2. The method of claim 1 , wherein the stimulation is applied after a penetrating injury to the subject's skin.

3. The method of claim 1 , wherein the infectious pathogens are bacteria.

4. The method of claim 1 , wherein the one or more peripheral nerves innervating the one or more lymph nodes drain a site of a penetrating injury to the subject's skin and stimulation of the one or more peripheral nerves innervating the one or more lymph nodes inhibits bacteremia and sepsis.

5. The method of claim 1 , wherein the stimulation of the one or more peripheral nerves comprises stimulation of femoral and sciatic nerves in the popliteal fascia.

6. The method of claim 1 , wherein the stimulation is electrical stimulation applied using a monopolar or bipolar needle electrode, a cluster of penetrating electrodes, percutaneous electrical nerve stimulation (PENS), transcutaneous electrical nerve stimulation (TENS), or a chronically implanted nerve stimulator.

7. The method of claim 1 , wherein the stimulation is applied for a duration of at least 1 minute.

8. The method of claim 1 , wherein the stimulation is applied in one session.

9. A method of inhibiting formation of metastases in a subject, the method comprising electrical and/or magnetic stimulation of one or more peripheral nerves innervating one or more lymph nodes draining a site of a primary tumor in the subject to restrict tumor cells and micrometastases from traveling through the subject's lymphatic system, wherein unrestricted travel of the tumor cells and micrometastases through the subject's lymphatic system leads to recolonization of cancer cells and formation of a metastatic tumor, thereby inhibiting the formation of metastases in the subject,

wherein the electrical stimulation of the one or more peripheral nerves comprises a train of 0.75 msec duration pulses applied at 2-20 Hz, or wherein the magnetic stimulation of the one or more peripheral nerves comprises a train of pulses applied at 2 Hz using an electromagnetic coil that creates a time-variable magnetic field.

10. The method of claim 9 , wherein the stimulation is electrical stimulation applied using a monopolar or bipolar needle electrode, a cluster of penetrating electrodes, percutaneous electrical nerve stimulation (PENS), transcutaneous electrical nerve stimulation (TENS), or a chronically implanted nerve stimulator.

11. A method of providing a vaccine adjuvant in a subject who has received a vaccine, the method comprising electrical and/or magnetic stimulation of one or more peripheral nerves innervating one or more lymph nodes of the subject who has received the vaccine to increase antibody production to an antigen present in the vaccine, thereby providing a vaccine adjuvant in the subject,

wherein the electrical stimulation of the one or more peripheral nerves comprises a train of 0.75 msec duration pulses applied at 2-20 Hz, or wherein the magnetic stimulation of the one or more peripheral nerves comprises a train of pulses applied at 2 Hz using an electromagnetic coil that creates a time-variable magnetic field.

12. The method of claim 11 , wherein the stimulation is electrical stimulation applied using a monopolar or bipolar needle electrode, a cluster of penetrating electrodes, percutaneous electrical nerve stimulation (PENS), transcutaneous electrical nerve stimulation (TENS), or a chronically implanted nerve stimulator.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE 2ND PROPERTY NUMBER PREVIOUSLY RECORDED AT REEL: 050188 FRAME: 0819-0826. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 10, 2020
From: THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
To: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
Reel/Frame 054372/0951 →
CHANGE OF NAME Recorded Aug 27, 2019
From: THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
To: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
Reel/Frame 050188/0819 →
Continuity (2)
Provisional Application 62296170 · Feb 17, 2016
Related Publication 20190038898A1 · Feb 7, 2019
Cited By (1)
US 12,377,272